Arch Capital Group Multi-line and other specialty — Year Three remained flat by 0.0% to 11.0% in Q4 2025 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from 11.0% to 11.0%.
Significant changes in Year Three development may indicate prior misestimation of claim severity or frequency.
This metric represents the loss development or claims activity specifically for the third year following the inception o...
Standard component of loss development triangles; peers report this as 'Development Year 3'.
acgl_segment_multi_line_and_other_specialty_year_three| Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|---|---|
| Value | 11% | 10.9% | 11.3% | 11% | 11% |
| QoQ Change | — | -0.9% | +3.7% | -2.7% | +0.0% |
| YoY Change | — | -0.9% | +3.7% | -2.7% | +0.0% |